Knowledge (XXG)

Patheon

Source 📝

24: 184:
Patheon does not own any of the licenses of the products it manufactures and is often listed as the manufacturer on packaging, with the product license holder's brand name, product name and corporate identity being used. Clients include such pharmaceutical brands as
106:
services offered under the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics and commercial manufacturing and packaging. In 2017, Patheon was acquired by
119:
Patheon was founded in Fort Erie, Ontario in 1974 as Custom Pharmaceuticals Ltd. In 1990, it began to expand to US markets. Custom Pharmaceuticals changed its name to Patheon in 1993 and was first publicly traded that year on the
499: 208:
In 2016, Patheon's manufacturing sites included sites in Canada, the continental US, Puerto Rico, France, the United Kingdom, Italy, Austria, Germany, the Netherlands, Japan, and Australia.
330: 146:, for $ 255 million. (Patheon changed the company's name the following year to "Banner Life Sciences"). In a $ 2.6 billion deal, Patheon merged with the pharmaceutical division of 484: 489: 298: 150:
in 2014 to become a joint venture after JLL Partners bought a controlling stake in the latter as well, adding significantly to Patheon's European production capacity.
345: 509: 403:"Thermo Fisher Scientific to Acquire Patheon for $ 7.2B - GEN Genetic Engineering & Biotechnology News - Biotech from Bench to Business - GEN" 514: 504: 266: 378: 494: 402: 321: 211:
Patheon manufactures products in various dosage forms including oral solids (tablets, capsules) and injectable sterile products (vials,
103: 162: 231: 289: 194: 173: 108: 75: 121: 51: 449: 360: 205:
and Avanir Pharmaceuticals. As of 2016, Patheon had manufactured or developed more than 800 products.
258: 420: 135:
provided Patheon $ 150 million to restructure. Two years later, after a failed takeover bid by
142:
In December 2012, Patheon acquired Banner Pharmacaps, a drug manufacturer specializing in
166: 70: 478: 186: 147: 235: 132: 136: 128: 158: 131:, US. The deal proved unprofitable, and in 2007, the New York equity firm 23: 190: 346:"Patheon propels itself into US biologics market in Gallus acquisition" 212: 143: 215:, pre-filled syringes containing liquids, powders and lyophilisates). 102:
is a service brand within Thermo Fisher Scientific's brand portfolio.
198: 154: 202: 361:"TRLPC-Patheon to raise 150 mln euro loan for IRIX acquisition" 139:, JLL Partners bought a controlling interest in the company. 127:
In 2004, Patheon acquired MOVA, a drug manufacturer based in
379:"Oregon pharma company sold to North Carolina manufacturer" 322:"JLL Forms New Pharma Firm With DSM in $ 2.6 Billion Deal" 104:
Contract development and manufacturing organization (CDMO)
469: 319:
Xu, Jodi; Carey, David; Noel, Andrew (19 November 2013).
86: 500:
Companies formerly listed on the New York Stock Exchange
176:
completed its acquisition of Patheon for $ 7.2 billion.
153:
In 2015, Patheon acquired Agere Pharmaceuticals, an
81: 69: 59: 46: 38: 30: 320: 288: 42:Contract Development Manufacturing Organization 8: 485:Pharmaceutical companies established in 1974 16: 490:Pharmaceutical companies of the Netherlands 290:"Patheon changing Banner Pharmacaps' name" 22: 15: 201:, with biotechnology customers including 223: 111:to form its Pharma Services business. 7: 65:Marc N. Casper (President & CEO) 169:, the latter for $ 162.78 million. 161:, and IRIX, a maker of specialist 14: 163:Active Pharmaceutical Ingredients 333:from the original on 2022-07-06. 359:Ruckin, Claire (9 March 2017). 301:from the original on 2016-06-04 269:from the original on 2022-01-06 259:"5 takeover failures revisited" 510:1974 establishments in Ontario 1: 515:2017 mergers and acquisitions 505:2016 initial public offerings 157:company specializing in drug 495:Companies based in Amsterdam 344:Stanton, Dan (26 Aug 2014). 257:Hodson, Peter (2013-12-13). 287:Evans, Matt (Jul 1, 2013). 531: 348:. BioPharma-Reporter.com. 234:. Patheon. Archived from 21: 421:"Patheon by the Numbers" 232:"History and Milestones" 174:Thermo Fisher Scientific 109:Thermo Fisher Scientific 76:Thermo Fisher Scientific 295:Triad Business Journal 180:Dosage Forms, Products 122:Toronto Stock Exchange 52:Waltham, Massachusetts 172:On August 29, 2017, 383:www.bizjournals.com 18: 470:Patheon home page 97: 96: 522: 458: 457: 446: 440: 439: 437: 435: 425: 417: 411: 410: 399: 393: 392: 390: 389: 375: 369: 368: 356: 350: 349: 341: 335: 334: 324: 316: 310: 309: 307: 306: 292: 284: 278: 277: 275: 274: 254: 248: 247: 245: 243: 228: 93: 90: 88: 26: 19: 530: 529: 525: 524: 523: 521: 520: 519: 475: 474: 466: 461: 448: 447: 443: 433: 431: 423: 419: 418: 414: 401: 400: 396: 387: 385: 377: 376: 372: 358: 357: 353: 343: 342: 338: 318: 317: 313: 304: 302: 286: 285: 281: 272: 270: 256: 255: 251: 241: 239: 230: 229: 225: 221: 182: 117: 85: 62: 55: 12: 11: 5: 528: 526: 518: 517: 512: 507: 502: 497: 492: 487: 477: 476: 473: 472: 465: 464:External links 462: 460: 459: 441: 412: 409:. 15 May 2017. 394: 370: 351: 336: 311: 279: 263:Financial Post 249: 222: 220: 217: 199:Sanofi Aventis 187:Merck & Co 181: 178: 167:South Carolina 116: 113: 95: 94: 83: 79: 78: 73: 67: 66: 63: 60: 57: 56: 50: 48: 44: 43: 40: 36: 35: 32: 28: 27: 13: 10: 9: 6: 4: 3: 2: 527: 516: 513: 511: 508: 506: 503: 501: 498: 496: 493: 491: 488: 486: 483: 482: 480: 471: 468: 467: 463: 455: 451: 445: 442: 429: 422: 416: 413: 408: 404: 398: 395: 384: 380: 374: 371: 366: 362: 355: 352: 347: 340: 337: 332: 328: 323: 315: 312: 300: 296: 291: 283: 280: 268: 264: 260: 253: 250: 238:on 2016-05-27 237: 233: 227: 224: 218: 216: 214: 209: 206: 204: 200: 196: 192: 188: 179: 177: 175: 170: 168: 164: 160: 156: 151: 149: 145: 140: 138: 134: 130: 125: 123: 114: 112: 110: 105: 101: 92: 84: 80: 77: 74: 72: 68: 64: 58: 53: 49: 45: 41: 37: 33: 29: 25: 20: 453: 444: 432:. Retrieved 427: 415: 406: 397: 386:. Retrieved 382: 373: 364: 354: 339: 326: 314: 303:. Retrieved 294: 282: 271:. Retrieved 262: 252: 240:. Retrieved 236:the original 226: 210: 207: 183: 171: 152: 148:Royal DSM NV 141: 133:JLL Partners 126: 118: 99: 98: 47:Headquarters 31:Company type 17:Patheon N.V. 428:patheon.com 137:Lonza Group 129:Puerto Rico 479:Categories 388:2022-01-06 305:2022-01-06 273:2022-01-06 219:References 159:solubility 61:Key people 34:Subsidiary 430:. Patheon 327:Bloomberg 331:Archived 299:Archived 267:Archived 213:ampoules 191:Novartis 144:softgels 89:.patheon 39:Industry 454:Patheon 450:"Sites" 434:May 18, 365:Reuters 242:May 18, 115:History 100:Patheon 82:Website 195:Takeda 155:Oregon 71:Parent 54:, U.S. 424:(PDF) 203:Amgen 436:2016 244:2016 197:and 91:.com 407:GEN 165:in 87:www 481:: 452:. 426:. 405:. 381:. 363:. 329:. 325:. 297:. 293:. 265:. 261:. 193:, 189:, 124:. 456:. 438:. 391:. 367:. 308:. 276:. 246:.

Index


Waltham, Massachusetts
Parent
Thermo Fisher Scientific
www.patheon.com
Contract development and manufacturing organization (CDMO)
Thermo Fisher Scientific
Toronto Stock Exchange
Puerto Rico
JLL Partners
Lonza Group
softgels
Royal DSM NV
Oregon
solubility
Active Pharmaceutical Ingredients
South Carolina
Thermo Fisher Scientific
Merck & Co
Novartis
Takeda
Sanofi Aventis
Amgen
ampoules
"History and Milestones"
the original
"5 takeover failures revisited"
Archived
"Patheon changing Banner Pharmacaps' name"
Archived

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.